Spindle cell proliferation spans the entire biological spectrum from completely harmless to aggressively malignant, and the elongated cell shape itself reveals almost nothing about which end of that spectrum a given growth falls on. Benign tumors like schwannomas and leiomyomas, locally aggressive but non-metastasizing conditions like desmoid fibromatosis, and outright cancers like leiomyosarcoma and sarcomatoid carcinoma all share the same basic spindle morphology under the microscope. This overlap is the central challenge in spindle cell pathology: it forces clinicians to look beyond cell shape and into immunohistochemistry, molecular testing, and clinical context to reach an accurate diagnosis.
Why the Same Cell Shape Can Mean Very Different Things
A “spindle cell” is not a specific cell type. It is a descriptive label for any cell that appears elongated and tapered at both ends when viewed on a slide. Fibroblasts, smooth muscle cells, nerve sheath cells, endothelial cells, and even epithelial cancer cells that have changed their behavior can all take on this appearance. Because so many different cell lineages can produce spindle-shaped proliferations, pathologists face an unusually broad list of possibilities when they encounter one in a biopsy. Histologically, these tumors can be arranged in fascicular, herringbone, or storiform patterns, and whether the growth is benign or malignant often depends on its histological subtype rather than its overall architecture.1Med Microbiol Rep. Spindle Cell Tumors: Understanding the Clinical Characteristics, Diagnosis, and Treatment
This is why two pathologists looking at the same slide can arrive at very different initial impressions. A bland-looking spindle cell proliferation might be a reactive process that will never cause harm, or it might be a deceptively low-grade malignancy. The clinical stakes of getting it wrong are high in both directions: calling a benign lesion malignant can lead to unnecessary surgery or chemotherapy, while underdiagnosing a sarcoma can delay life-saving treatment.
Benign Spindle Cell Growths
Many of the most common spindle cell proliferations are entirely benign. Schwannomas and neurofibromas, both arising from the nerve sheath, are classic examples. Schwannomas are encapsulated, slow-growing, and cured by surgical removal in the vast majority of cases. Neurofibromas are more diffuse but still typically benign, though the plexiform variant seen in neurofibromatosis carries a meaningful risk of malignant transformation. Distinguishing these subtypes and their diagnostically challenging variants from malignant peripheral nerve sheath tumors (MPNST) remains one of the harder problems in soft tissue pathology.2PubMed Central. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems
Smooth muscle tumors provide another clear illustration. Uterine leiomyomas, commonly known as fibroids, are among the most frequent tumors in the human body and are overwhelmingly benign. They consist of spindle-shaped smooth muscle cells arranged in whorled bundles. Most never require treatment beyond monitoring. Leiomyomas also occur in the gastrointestinal tract, where they are one of the common gastric spindle cell tumors alongside GISTs and schwannomas.
Nodular fasciitis deserves special mention because it is arguably the most misdiagnosed spindle cell lesion. It grows rapidly, sometimes doubling in size within days, which raises alarm for malignancy. Under the microscope, the cells can look active and mitotically busy. But nodular fasciitis is a self-limiting process. Research has identified a rearrangement of the USP6 gene as a recurring and specific finding in these lesions, confirming that nodular fasciitis represents a clonal neoplastic proliferation rather than a purely reactive one, yet one that still behaves in a benign fashion.3PubMed Central. Nodular fasciitis of the face: A case report Getting this diagnosis right matters enormously because radical surgery for what is essentially a harmless lump would be an overreaction.
The Gray Zone Between Benign and Malignant
Not every spindle cell proliferation slots neatly into “benign” or “malignant.” Some occupy a frustrating middle ground. Desmoid-type fibromatosis is the best-known example: it does not metastasize but can be deeply infiltrative, wrapping around nerves and blood vessels and recurring stubbornly after excision. The disease is driven by mutations in the CTNNB1 gene, which leads to abnormal activation of a key growth signaling pathway. In a systematic analysis of over 200 cases, CTNNB1 mutations were found in roughly 89% of adult desmoid tumors and about 77% of pediatric cases.4Scientific Reports. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis – A systematic analysis of 204 cases
These intermediate lesions pose a clinical dilemma. They will not kill you through metastasis, but they can cause severe local problems, compressing organs and eroding tissue. Treatment strategies range from watchful waiting to aggressive surgery, and for some patients the tumor recurs regardless. Because the CTNNB1 mutation status is so consistent, it has become a useful molecular marker to confirm the diagnosis and distinguish desmoid fibromatosis from sarcomas that could look similar under the microscope.
Malignant Spindle Cell Sarcomas
On the malignant end of the spectrum, spindle cell sarcomas include some of the most challenging cancers to treat. Leiomyosarcoma, the malignant counterpart of the benign leiomyoma, arises from smooth muscle and frequently occurs in the uterus, retroperitoneum, and extremities. Uterine leiomyosarcoma carries a particularly poor prognosis, partly because it can be mistaken for a benign fibroid until surgery reveals its true nature. Molecular studies show that the vast majority of uterine leiomyosarcomas harbor genomic alterations in tumor suppressor genes like TP53, RB1, and ATRX, with about 80% of tumors carrying changes in at least two of these genes.5Modern Pathology. Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
Synovial sarcoma is another important malignant spindle cell tumor, despite its misleading name (it has nothing to do with joints). The monophasic fibrous variant, which accounts for the large majority of cases, consists almost entirely of spindle cells and can be difficult to distinguish from other spindle cell malignancies on morphology alone. Immunohistochemical markers like Bcl-2 and cytokeratin help narrow the diagnosis, with Bcl-2 showing strong positivity in the spindle cells of both monophasic and biphasic variants.6PubMed Central. Synovial sarcoma with relevant immunocytochemistry and special emphasis on the monophasic fibrous variant
A population-based analysis of spindle cell sarcoma using a large cancer registry identified over 3,200 cases, with a median age at diagnosis of 57 years and no strong gender predisposition. Age over 64, advanced stage at diagnosis, and treatment without surgery were all independently associated with worse survival outcomes.7Nature / Scientific Reports. Spindle cell sarcoma: a SEER population-based analysis Surgical removal remains the cornerstone of treatment for localized disease, and specific molecular abnormalities in sarcomas have opened doors to targeted therapy, including fusion proteins that serve as both diagnostic markers and potential drug targets.8PubMed Central. Targeted therapy for sarcomas
When Carcinomas Acquire a Spindle Shape
One of the most confusing scenarios in spindle cell pathology occurs when a carcinoma, a cancer arising from epithelial tissue, transforms into something that looks like a sarcoma under the microscope. This happens through a process called epithelial-mesenchymal transition (EMT), in which epithelial cells lose their usual characteristics and take on properties associated with mesenchymal cells, including a spindle shape and increased ability to invade surrounding tissue.9PubMed Central. Epithelial-Mesenchymal Transition as a Pathogenetic Mechanism of Sarcomatoid Carcinoma and Carcinosarcoma
Sarcomatoid carcinomas can arise in many organs, including the kidney, lung, and bladder. In clear cell renal cell carcinoma, the sarcomatoid component shows enhanced expression of mesenchymal markers compared with the conventional carcinoma areas, and research has identified transforming growth factor beta as a potential driving force behind this conversion. When cultured kidney cancer cells were exposed to this growth factor in the laboratory, they adopted a spindle morphology similar to what is seen in sarcomatoid tumors.10PubMed. Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition Sarcomatoid change in a carcinoma generally signals a more aggressive tumor with worse outcomes, making correct identification critical for treatment planning.
In the urinary bladder, distinguishing sarcomatoid carcinoma from true sarcomas and from a reactive spindle cell proliferation called pseudosarcomatous myofibroblastic proliferation requires a carefully chosen panel of immunohistochemical stains. Certain marker combinations point toward one diagnosis over others: broad-spectrum cytokeratin and smooth muscle actin positivity along with ALK staining favor the reactive proliferation, while expression of specific high-molecular-weight cytokeratins with p63 points toward sarcomatoid carcinoma, and smooth muscle actin positivity in the absence of other markers suggests leiomyosarcoma.11The American Journal of Surgical Pathology. Utility of a Comprehensive Immunohistochemical Panel in the Differential Diagnosis of Spindle Cell Lesions of the Urinary Bladder
Spindle Cell Melanoma and Its Diagnostic Pitfalls
Melanoma is primarily thought of as an epithelioid tumor, but a significant subset takes on a spindle cell morphology that can be remarkably deceptive. Spindle cell melanoma and desmoplastic melanoma differ in prognosis and treatment approach, yet their overlapping microscopic features make distinguishing them a genuine challenge.12Modern Pathology. A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma
The difficulty compounds when spindle cell melanoma metastasizes. On fine-needle aspiration specimens, about 9% of metastatic spindle cell melanoma cases failed to show any of the classic features pathologists rely on. The spindle cells ranged from bland cells that mimicked harmless fibroblasts to highly abnormal cells indistinguishable from aggressive sarcomas. In roughly 20% of cases, the metastasis looked entirely different from the primary tumor, which had shown the more typical epithelioid cell type. Spindle cell melanomas also tend to lose their usual melanoma markers, making them harder to identify with standard immunohistochemical stains.13PubMed. Diagnostic challenges of metastatic spindle cell melanoma on fine-needle aspiration specimens This is one of the reasons pathologists use expanded antibody panels rather than relying on a single marker when a spindle cell tumor raises suspicion for melanoma.
How Pathologists Sort It Out
Because cell shape alone cannot distinguish a benign nerve sheath tumor from a sarcoma, pathologists lean heavily on immunohistochemistry, a technique that uses antibodies to detect specific proteins in tissue. Different spindle cell tumors express different combinations of markers, and overlapping or absent staining patterns make panels of multiple antibodies essential. Lineage markers for smooth muscle, skeletal muscle, endothelial cells, epithelial cells, and Schwann cells are all used routinely, and the loss of certain differentiation markers in malignant tumors often means that no single stain provides the answer.14PubMed Central. A practical and comprehensive immunohistochemical approach to the diagnosis of superficial soft tissue tumors The overlapping clinical, radiographic, and microscopic features of spindle cell lesions compound the problem, making immunohistochemistry essential rather than optional.15Journal of Cancer Research and Therapeutics. Spindle cell lesions: A review on immunohistochemical markers
This challenge is especially intense in the head and neck region, where the range of possible spindle cell lesions runs from benign reactive processes all the way to highly aggressive cancers. Spindle cell carcinoma of the upper aerodigestive tract, for instance, can mimic benign or non-neoplastic spindle cell conditions, and several benign lesions can in turn mimic carcinoma.16PubMed Central. Spindle cell lesions–neoplastic or non-neoplastic?: spindle cell carcinoma and other atypical spindle cell lesions of the head and neck Getting these wrong in either direction has serious consequences for patients.
Molecular Fingerprints and Fusion Genes
When immunohistochemistry alone cannot settle the question, molecular testing increasingly provides the tiebreaker. Many spindle cell sarcomas carry characteristic genetic changes, especially chromosomal translocations that create fusion genes. These fused genes produce abnormal proteins that drive tumor growth and, in many cases, are specific enough to serve as molecular fingerprints for diagnosis.
In one spindle cell sarcoma studied by whole-transcriptome sequencing, researchers identified four distinct fusion genes, all involving partner genes mapping to the long arm of chromosome 12, alongside amplification of the MDM2 oncogene.17PubMed Central. Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification Similarly, a group of spindle cell tumors were found to harbor RET gene fusions, all with the same breakpoint in exon 12 retaining the tyrosine kinase domain, paired with various partner genes. These RET-fusion tumors showed a morphologic range similar to tumors driven by NTRK gene fusions, underscoring how molecular testing can reveal connections between tumors that look different on a slide and distinguish tumors that look identical.18PubMed Central. Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions
For gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumor of the GI tract, mutations in the KIT and PDGFRA genes define the molecular landscape and guide treatment decisions. KIT mutations, particularly those in exon 11, are found predominantly in spindle cell GISTs, while PDGFRA mutations cluster in epithelioid or mixed tumors.19PubMed Central. Molecular Profiling of KIT/PDGFRA-Mutant and Wild-Type Gastrointestinal Stromal Tumors (GISTs) with Clinicopathological Correlation: An 18-Year Experience at a Tertiary Center in Kuwait20Journal of Clinical Pathology. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated This association between mutation type and cell morphology is not just a laboratory curiosity. KIT exon 11 mutations predict responsiveness to imatinib, a targeted drug that transformed the treatment of advanced GIST from essentially untreatable to often controllable.
Spindle Cell Tumors in Children
Pediatric spindle cell tumors present their own set of challenges. Infantile fibrosarcoma is the most common soft tissue sarcoma in children under one year of age and is defined molecularly by NTRK fusion proteins. Despite the alarming name, it generally has a much better prognosis than adult fibrosarcoma and responds well to chemotherapy. TRK inhibitors, drugs that specifically target the NTRK fusion protein, have added another treatment option. However, rare cases progress and metastasize. One reported case demonstrated progressive disease with multiple acquired mutations, including changes in TP53 and a gatekeeper mutation in the NTRK gene that conferred resistance to TRK inhibitor therapy.21PubMed Central. Progressive metastatic infantile fibrosarcoma with multiple acquired mutations This pattern of acquired resistance parallels what oncologists see in adult cancers and highlights why even tumors with favorable molecular profiles require careful monitoring.
The Kaposi’s sarcoma spindle cell offers yet another twist on cell origin. For years, the lineage of these cells was debated. Electron microscopy and immunohistochemistry eventually pointed to an endothelial origin, and more recent work using lymphatic-specific markers like podoplanin and gene expression studies strongly linked the spindle cells specifically to the lymphatic endothelial lineage rather than blood vessel endothelium.22PubMed. Spindle cells and their role in Kaposi’s sarcoma This distinction matters for understanding why the disease behaves the way it does and for developing more precise therapies.
How the Surrounding Tissue Shapes Tumor Behavior
The behavior of a spindle cell tumor depends not only on the tumor cells themselves but also on the surrounding extracellular matrix, the meshwork of proteins and carbohydrates that provides structural support and biochemical signals to cells. One large proteoglycan called versican, which regulates cell proliferation, adhesion, and migration, shows a telling pattern: in mesenchymal spindle cell tumors it accumulates inside the cells, while in epithelial tumors it sits outside in the surrounding matrix. This differential expression may be linked to how spindle cell tumors differentiate, progress, and spread, and it distinguishes them biologically from epithelial cancers in ways that go beyond morphology.23Applied Immunohistochemistry & Molecular Morphology. Intracellular Versican Expression in Mesenchymal Spindle Cell Tumors Contrasts With Extracellular Expression in Epithelial and Other Tumors—A Tissue Microarray-based Study
In uveal melanoma, remodeling of the extracellular matrix plays an active role in promoting tumor cell invasion and metastasis, with spindle cell and mixed histotypes showing distinct patterns of invasive behavior shaped by how the tumor remodels its surrounding tissue.24Fyodorov journal of ophthalmic surgery. Features of invasive phenotype formation in spindle-cell and mixed histotypes of human uveal melanoma These findings suggest that understanding the tumor’s relationship with its microenvironment, not just its cell morphology, will be increasingly important for predicting behavior and guiding treatment.
Computational Approaches to Classification
Given how much diagnostic difficulty spindle cell tumors cause, there is growing interest in using artificial intelligence to help pathologists classify them. A recent study developed a neural network to classify gastric spindle cell tumors into GISTs, leiomyomas, and schwannomas directly from routine stained whole-slide images. No automated pipeline for this specific task had previously been proposed, and the effort reflects a broader push to reduce the workload and subjectivity involved in diagnosing tumors where even experienced pathologists can disagree.25PubMed. Subtype classification of gastric spindle cell tumors in whole slide images
These tools are not replacing pathologists. The diagnostic decision for spindle cell lesions still integrates clinical history, imaging, histology, immunohistochemistry, and increasingly molecular data in a way that requires human judgment. But automated pre-screening could flag ambiguous cases for expert review, reduce turnaround times, and provide a second opinion in settings where subspecialty soft tissue pathology expertise is not available on site. For a group of tumors where looking alike is the rule rather than the exception, any tool that sharpens classification has real clinical value.